Parkia speciosa empty pod extract exerts anti-inflammatory properties by modulating NFκB and MAPK pathways in cardiomyocytes exposed to tumor necrosis factor-α
Sign Up to like & getrecommendations! Published in 2018 at "Cytotechnology"
DOI: 10.1007/s10616-018-0267-8
Abstract: Parkia speciosa Hassk is a plant found abundantly in the Southeast Asia region. Its seeds, with or without pods, have been used in traditional medicine locally to treat cardiovascular problems. The pathogenesis of cardiovascular diseases… read more here.
Keywords: pse; tnf; parkia speciosa; factor ... See more keywords
Assessment and comparison of phytochemical constituents and biological activities of bitter bean (Parkia speciosa Hassk.) collected from different locations in Malaysia
Sign Up to like & getrecommendations! Published in 2018 at "Chemistry Central Journal"
DOI: 10.1186/s13065-018-0377-6
Abstract: BackgroundParkia speciosa seeds are a common ingredient in Malay cuisine with traditional interest because of its medicinal importance and content of health-promoting phytochemicals. This study evaluated the phytochemical constituents and biological activities (antioxidant and antibacterial… read more here.
Keywords: seed; phytochemical constituents; biological activities; constituents biological ... See more keywords
Phytochemical Contents and Pharmacological Potential of Parkia speciosa Hassk. for Diabetic Vasculopathy: A Review
Sign Up to like & getrecommendations! Published in 2022 at "Antioxidants"
DOI: 10.3390/antiox11020431
Abstract: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia and is considered a major health problem in the world. It is associated with endothelial dysfunction which causes progressive vascular damage. DM is a known… read more here.
Keywords: pharmacological potential; phytochemical contents; review; diabetic vasculopathy ... See more keywords
Parkia speciosa Hassk. Empty Pod Extract Prevents Cardiomyocyte Hypertrophy by Inhibiting MAPK and Calcineurin-NFATC3 Signaling Pathways
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life13010043
Abstract: Cardiac hypertrophy is an early hallmark during the clinical course of heart failure. Therapeutic strategies aiming to alleviate cardiac hypertrophy via the mitogen-activated protein kinase (MAPK)/calcineurin-nuclear factor of activated T-cells (NFAT) signaling pathway may help… read more here.
Keywords: cardiomyocyte hypertrophy; hypertrophy; calcineurin; empty pod ... See more keywords